Literature DB >> 28769302

LONG TERM VENOUS ACCESS IN PATIENTS WITH ACUTE LEUKEMIA AND HIGH GRADE LYMPHOMAS (Based on AFMRC Project 1868/91).

Rajat Kumar1, R Ranga Rao2, G Rajagopal3, V P Singh3.   

Abstract

Twenty Hickman catheters were passed in 19 patients undergoing chemotherapy for acute leukemia (15 patients) and high grade lymphoma (4 patients). The catheters were inserted into the superior vena cava through the cephalic or external jugular vein with subcutaneous tunneling and exit through the anterior chest wall, and were functionally effective in 19 cases. The catheters remained in situ for a mean period of 50.5 days (range 1-266 days). The catheters were well tolerated eliminating the need for repeated venepuncture. The complications encountered were: hemorrhage - 1 case, thrombosis - 1 case, catheter related bacteremia - 2 cases, tunnel infection - 1 case, and exit site infection - 5 cases. Most of the complications were managed conservatively. These catheters ensured safe and reliable venous access in these high risk patients during episodes of severe neutropenia, sepsis and thrombocytopenia.

Entities:  

Keywords:  Catheterisation central venous; Leukemia; Lymphoma

Year:  2017        PMID: 28769302      PMCID: PMC5530224          DOI: 10.1016/S0377-1237(17)30980-2

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  9 in total

1.  A modified right atrial catheter for access to the venous system in marrow transplant recipients.

Authors:  R O Hickman; C D Buckner; R A Clift; J E Sanders; P Stewart; E D Thomas
Journal:  Surg Gynecol Obstet       Date:  1979-06

2.  A silicone rubber atrial catheter for prolonged parenteral alimentation.

Authors:  J W Broviac; J J Cole; B H Scribner
Journal:  Surg Gynecol Obstet       Date:  1973-04

3.  Defining the risks of subclavian-vein catheterization.

Authors:  W D Haire; R P Lieberman
Journal:  N Engl J Med       Date:  1994-12-29       Impact factor: 91.245

Review 4.  Management of fever in patients with cancer and treatment-induced neutropenia.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

5.  Prolonged venous access for chemotherapy by means of the Hickman catheter.

Authors:  W P Reed; K A Newman; C de Jongh; J C Wade; S C Schimpff; P H Wiernik; J S McLaughlin
Journal:  Cancer       Date:  1983-07-01       Impact factor: 6.860

6.  Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation.

Authors:  W D Haire; R P Lieberman; J Edney; W P Vaughan; A Kessinger; J O Armitage; J C Goldsmith
Journal:  Cancer       Date:  1990-09-01       Impact factor: 6.860

7.  The value of prophylactic antibiotics during the insertion of long-term indwelling silastic right atrial catheters in cancer patients.

Authors:  M B Al-Sibai; E J Harder; R W Faskin; G W Johnson; M A Padmos
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

8.  A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies.

Authors:  S H Lim; M P Smith; S J Machin; A H Goldstone
Journal:  Eur J Haematol Suppl       Date:  1993

9.  Hickman catheter implantation in the treatment of acute leukaemia.

Authors:  J Hariharan; R Korula; M Chandy
Journal:  J Assoc Physicians India       Date:  1991-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.